Shifting Gears in Biotech: Edgewise Gains Ground on Pipeline Bets as Heidelberg Pharma Sharpens Corporate Focus
It is a telling day in the biopharmaceutical ecosystem. Investors are parsing through everything from technical market momentum in rare disease therapeutics to sweeping governance shakeups in European oncology innovators. Today’s market movements showcase the…